Adenosine Monophosphate-activated Protein Kinase (AMPK) Activators For the Prevention, Treatment and Potential Reversal of Pathological Pain

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|17|8|908-920

ISSN： 1389-4501

Source： Current Drug Targets, Vol.17, Iss.8, 2016-06, pp. : 908-920

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

5'-Adenosine Monophosphate-Activated Protein Kinase and the Metabolic Syndrome

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 11, Iss. 3, 2011-01 ,pp. : 206-216

Bentham Science Publishers

Access to resources Recommend Favorite

In silico Analysis of AMP-activated Protein Kinase and Ligand-based Virtual Screening for Identification of Novel AMPK Activators

By  

Current Computer - Aided Drug Design, Vol. 13, Iss. 3, 2017-07 ,pp. : 222-233

Bentham Science Publishers

Access to resources Recommend Favorite

Activation of AMP-activated protein kinase (AMPK) inhibits protein synthesis: a potential strategy to prevent the development of cardiac hypertrophy

By Chan Anita Y.M   Dyck Jason R.B  

Canadian Journal of Physiology and Pharmacology, Vol. 83, Iss. 1, 2005-01 ,pp. : 24-28

NRC Research Press

Access to resources Recommend Favorite

Computer-Aided Drug Design for AMP-Activated Protein Kinase Activators

By  

Current Computer - Aided Drug Design, Vol. 7, Iss. 3, 2011-01 ,pp. : 214-227

Bentham Science Publishers

Access to resources Recommend Favorite

Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated Protein Kinase (AMPK) Activators

By  

Letters in Drug Design & Discovery, Vol. 11, Iss. 6, 2014-07 ,pp. : 778-785

Bentham Science Publishers

Access to resources Recommend Favorite